| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 2T6D2HPX7Q |
Structure
| InChI Key | ADFCQWZHKCXPAJ-GFCCVEGCSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C15H14O3 |
| Molecular Weight | 242.27 |
| AlogP | 2.82 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 49.69 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 18.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Estrogen receptor beta agonist | Other |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
- | 74131 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Hyperplasia | 2 | D011470 | ClinicalTrials |
| Menopause | 2 | D008593 | ClinicalTrials |
| Alzheimer Disease | 1 | D000544 | ClinicalTrials |
| Breast Neoplasms | 0 | D001943 | ClinicalTrials |
Related Entries
Scaffolds
Cross References
| Resources | Reference |
|---|---|
| ChEBI | 34741 |
| ChEMBL | CHEMBL198877 |
| DrugBank | DB11674 |
| EPA CompTox | DTXSID0022309 |
| FDA SRS | 2T6D2HPX7Q |
| Human Metabolome Database | HMDB0002209 |
| KEGG | C14131 |
| SureChEMBL | SCHEMBL43647 |
| ZINC | ZINC000000388661 |
CONTENTS